$GRAL News

GRAIL, Inc. (GRAL) Shareholder/Analyst Call - Slideshow

GRAIL, Inc. (GRAL) Shareholder/Analyst Call Transcript

GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

GRAIL to Present at the 2026 Jefferies Global Healthcare Conference

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead

GRAIL, Inc. (GRAL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

How The GRAIL (GRAL) Narrative Is Shifting After NHS Galleri Results And Reimbursement Questions

TD Cowen Maintains Buy on GRAIL, Raises Price Target to $69

Piper Sandler Maintains Neutral on GRAIL, Raises Price Target to $56

GRAIL Q1 Earnings Call Highlights

GRAIL, Inc. (GRAL) Q1 2026 Earnings Call Transcript

GRAIL INC (NASDAQ:GRAL) Stock Falls After-Hours Despite Q1 Beat and Galleri Test Volume Surge

GRAIL Reports First Quarter 2026 Financial Results

GRAIL to Present at the BofA Securities 2026 Health Care Conference

GRAIL to Announce First Quarter 2026 Financial Results

GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting

GRAIL To Reveal New Data From NHS-Galleri And PATHFINDER 2 At 2026 ASCO Annual Meeting

A Look At GRAIL (GRAL) Valuation After New Galleri Integrations With Epic Junction And Superpower

Mizuho Initiates Coverage On GRAIL with Neutral Rating, Announces Price Target of $58

Piper Sandler Initiates Coverage On GRAIL with Neutral Rating, Announces Price Target of $54